Answer
Cobicistat-containing medicines are expected to increase the risk of systemic corticosteroid side effects with Ryaltris; avoid the combination unless benefits outweigh this increased risk, in which case patients should be monitored for these effects.
Sources for this answer
- Ryaltris 25 micrograms/actuation+600 micrograms/actuation Nasal Spray, suspensionGlenmark Pharmaceuticals Europe Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 5Document updated
Sources checked